 CHICAGO, July 15, 2021 PRNewswire -- P alo Santo , the leading U.S.-based psychedelic investment fund, announced its launch with an initial 35 million in capital raised and an active portfolio of 20 companies. The diversified venture fund is focused on tackling the growing global mental health crisis by investing in innovative psychedelic-based and adjacent therapies that are poised to shape the future of psychiatry and fields beyond. 